Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration has cleared an assay on Quidel's Solana platform to detect and differentiate herpes simplex viruses types 1 and 2 and varicella-zoster virus.

The test does not require upfront DNA extraction, detecting HSV-1, HSV-2, and VZV DNA in cutaneous or mucocutaneous lesion samples from symptomatic patients, including specimens collected in transport media. The Solana platform employs the firm's helicase-dependent amplification technology, and processes up to 12 samples per run, with run time of about one-hour.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Apr
06
Sponsored by
Beckman Coulter

In this webinar session, Dr. David Harris and Dr. Ryan Sprissler, who led the student and employee testing program at University of Arizona, will discuss how the university has remained physically open with nearly 25 percent of its population on campus, while keeping infection rates below 2 percent.

Apr
16
Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.